Novartis Didn't Properly Test Hypertension Drugs, Suit Says

Law360, New York (April 16, 2013, 1:51 PM EDT) -- Novartis AG has been hit with a lawsuit in New Jersey federal court alleging a woman was injured by the company’s hypertension drugs Valturna and Tekturna because the company didn’t test them properly, according to a notice of removal filed Friday.

Plaintiff Dottie Dodson said she was prescribed Valturna in 2010 in combination with Benicar, another anti-hypertensive drug, and later in combination with Tekturna, leading to chronic kidney disease and end-stage renal failure in 2011. She alleges Novartis discovered the drugs should not be taken in...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

DODSON v. NOVARTIS INTERNATIONAL AG et al


Case Number

2:13-cv-02365

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

William H. Walls

Date Filed

April 12, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.